Women in NI encouraged to attend life-saving cervical screening when invited

Women in NI encouraged to attend life-saving cervical screening when invited

Women in NI encouraged to attend life-saving cervical screening when invited

A new detection method rolled out last month looks for traces of the human papillomavirus (HPV), which cause almost all cervical tumours.

More than 350 persons were apprised of simple measures that could be adopted to prevent the completely preventable cancer.

Cervical screening can prevent around 45 percent of cervical cancer cases in women in their 30s, rising with age to 75 percent in women in their 50s and 60s, who attend regularly.

It is on the above premise that Chain Reactions Nigeria, a leading public relations and integrated communication consulting firm, is partnering St. Ives, a multi-specialist hospital, to reduce the scourge of cervical cancer in the country in further demonstration of its commitment to Corporate Social Investment.

According the Lincolnshire CCGs, research shows that both awareness of cervical cancer and uptake of screening are considerably lower amongst women from minority ethnic communities in comparison to the wider population.

Speaking about the campaign, Managing Director/Chief Strategist, Chain Reactions Nigeria, Israel Jaiye Opayemi, said: "Women are gatekeepers of life".

It is too soon for the vaccine to have stopped most cases of actual cancer, which may take decades to develop so is more common among older people. Truth is, whatever affects the women in our lives, affects every one of us. About 250 underprivileged women have been provided free Cervical Cancer screening. This is the age group where screening is of most benefit. About 400 cases a year are in women aged 25 to 29.

When the vaccination programme began, around 15 per cent of sexually-active young women had types 16 or 18 while 10 per cent had 6 or 11.

"Alongside pap screening and evaluation of abnormal pap smear, other gender-specific conditions women face such as female sexual dysfunction, menstrual abnormalities, contraception counselling and provision of different contraceptive options, vaginitis, STD testing and treatment, among others", she explained. Bottom line is HPV vaccine helps prevent cancer.

"So it's estimated as many as 90-95 percent of people in the USA have a strain of HPV".

If these abnormalities are left untreated they can lead to cancer of the cervix (the neck of the womb).

If HPV is present but no cell changes have occurred, most are invited for a second screening in a year's time.

Related news

[an error occurred while processing the directive]